Essex Woodlands Management as of Sept. 30, 2019
Portfolio Holdings for Essex Woodlands Management
Essex Woodlands Management holds 6 positions in its portfolio as reported in the September 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Eyepoint Pharmaceuticals | 47.2 | $76M | 42M | 1.81 | |
| Revance Therapeutics (RVNC) | 27.1 | $43M | 3.3M | 13.00 | |
| Axogen (AXGN) | 18.9 | $30M | 2.4M | 12.48 | |
| MediciNova (MNOV) | 5.9 | $9.5M | 1.2M | 8.15 | |
| Endologix | 0.6 | $998k | 126k | 7.94 | |
| Catalyst Biosciences | 0.2 | $386k | 79k | 4.91 |
